1140 Participants Needed

Perceptual Learning Approaches for Cognitive Impairment

Recruiting at 2 trial locations
AA
Overseen ByAudrey A Carrillo, MA
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Wisconsin, Madison
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This is a research study about how training can impact performance on cognitive tasks. Participants are between 18 and 30 and 60 to 85 years of age, have normal (or corrected to normal) vision, and have no neurological conditions that would preclude their ability to complete computerized cognitive tasks. Up to 1140 participants will be on study for up to 8 weeks.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Perceptual Learning Approaches for Cognitive Impairment?

Research shows that cognitive training can improve attention and processing speed in older adults, and auditory training enhances the perception of complex sounds and speech. These findings suggest that perceptual learning approaches, which include attention and auditory training, may help improve cognitive function in individuals with cognitive impairment.12345

Is perceptual learning safe for humans?

Research on perceptual learning, including audio-visual training, shows it can improve cognitive abilities in older adults without reported safety concerns, suggesting it is generally safe for humans.678910

How does the treatment 'Perceptual Learning Approaches for Cognitive Impairment' differ from other treatments for cognitive impairment?

This treatment is unique because it uses perceptual learning, which involves training the brain to improve sensory and attentional functions through repeated practice. Unlike traditional drug treatments, it leverages the brain's plasticity to enhance cognitive abilities, making it a non-invasive option that can be tailored to individual needs.311121314

Research Team

CS

C. Shawn Green

Principal Investigator

University of Wisconsin, Madison

Eligibility Criteria

This trial is for individuals between 18 and 30 years old with corrected vision of at least 20/40. They should not have any history of retinal pathology or neurological disease.

Inclusion Criteria

I am between 18 and 30 years old.
Corrected vision of 20/40 or better (as assessed with an eye chart)
I do not have any eye or neurological diseases.

Exclusion Criteria

I have a diagnosed eye condition affecting my retina.
Corrected vision of 20/40 or worse

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Training

Participants undergo perceptual learning tasks across 12 separate conditions to assess the effects of training on cognitive and perceptual performance.

5-8 weeks
Multiple sessions (in-person or virtual)

Crossover Training

Younger cohort participants undergo a crossover design to train on two tasks sequentially to examine learning and generalization.

5-8 weeks

Follow-up

Participants are monitored for safety and effectiveness after training, with assessments on transfer to visual search, auditory attention, and reading.

4 weeks

Treatment Details

Interventions

  • Complex Features (CF)
  • Endogenous Attention Training (EnAT)
  • Exogenous Attention Training (ExAT)
  • Long Training (LT)
  • Mixed Difficulty (MD)
  • Multisensory Facilitation (MF)
  • No Contact Control
  • Noise Training (NT)
  • Parafoveal Training (PT)
  • Short Staircases (SS)
  • Standard Perceptual Learning (SPL)
  • Stimulus Variety (SV)
  • Training with Flankers (TWF)
Trial OverviewThe study tests various training tasks (like mixed difficulty, attention training, noise training) to see how they affect perceptual learning in people with cognitive impairment. It aims to understand which methods improve perception skills the most.
Participant Groups
18Treatment groups
Experimental Treatment
Group I: OA5 - No Contact ControlExperimental Treatment1 Intervention
Participants in older cohort will complete NCC condition.
Group II: OA4 - Stimulus VarietyExperimental Treatment1 Intervention
Participants in older cohort will complete SV condition.
Group III: OA3 - Training with FlankersExperimental Treatment1 Intervention
Participants in older cohort will complete TWF condition.
Group IV: OA2 - Noise TrainingExperimental Treatment1 Intervention
Participants in older cohort will complete NT condition.
Group V: OA1 - Standard Perceptual LearningExperimental Treatment1 Intervention
Participants in older cohort will complete SPL condition.
Group VI: No Contact ControlExperimental Treatment13 Interventions
Participants in younger cohort will complete NCC training during the first phase of training. In the cross-over they will then complete either SPL, LT, SS, MD, NT, TWF, PT, SV, CF, ExAT, EnAT, MF, NCC.
Group VII: C9 - Exogenous Attention Training (ExAT)Experimental Treatment3 Interventions
Participants in younger cohort will complete ExAT training during the first phase of training. In the cross-over they will then complete either ExAT, PT, NCC.
Group VIII: C8a - Complex Features (CF)Experimental Treatment3 Interventions
Participants in younger cohort will complete CF training during the first phase of training. In the cross-over they will then complete either CF, PT, NCC.
Group IX: C8 - Stimulus Variety (SV)Experimental Treatment3 Interventions
Participants in younger cohort will complete SV training during the first phase of training. In the cross-over they will then complete either SV, PT, or NCC.
Group X: C7 - Parafoveal Training (PT)Experimental Treatment7 Interventions
Participants in younger cohort will complete PT training during the first phase of training. In the cross-over they will then complete either PT, SV, CF, ExAT, EnAT, MF, or NCC.
Group XI: C6 - Training with Flankers (TWFExperimental Treatment3 Interventions
Participants in younger cohort will complete TWF training during the first phase of training. In the cross-over they will then complete eitherTWF, SPL, or NCC.
Group XII: C5 - Noise Training (NT)Experimental Treatment3 Interventions
Participants in younger cohort will complete NT training during the first phase of training. In the cross-over they will then complete either NT, SPL, or NCC.
Group XIII: C4 - Mixed Difficulty (MD)Experimental Treatment3 Interventions
Participants in younger cohort will complete MD training during the first phase of training. In the cross-over they will then complete either MD, SPL, or NCC.
Group XIV: C3 - Short Staircases (SS)Experimental Treatment3 Interventions
Participants in younger cohort will complete SS training during the first phase of training. In the cross-over they will then complete either SS, SPL, or NCC.
Group XV: C2 - Long Training (LT)Experimental Treatment3 Interventions
Participants in younger cohort will complete LT training during the first phase of training. In the cross-over they will then complete either LT, SPL, or NCC.
Group XVI: C11 - Multisensory Facilitation (MF)Experimental Treatment3 Interventions
Participants in younger cohort will complete MF training during the first phase of training. In the cross-over they will then complete either MF, PT, NCC.
Group XVII: C10 - Endogenous Attention Training (EnAT)Experimental Treatment3 Interventions
Participants in younger cohort will complete EnAT training during the first phase of training. In the cross-over they will then complete either EnAT, PT, NCC.
Group XVIII: C1 - Standard Perceptual Learning (SPL)Experimental Treatment7 Interventions
Participants in younger cohort will complete SPL training during the first phase of training. In the cross-over they will then complete either SPL, LT, SS, MD, NT, TWF, or NCC.

Complex Features (CF) is already approved in European Union, United States for the following indications:

🇪🇺
Approved in European Union as Lynparza for:
  • Breast cancer
  • Ovarian cancer
  • Fallopian tube cancer
  • Peritoneal cancer
  • Pancreatic cancer
  • Prostate cancer
  • Endometrial cancer
🇺🇸
Approved in United States as Lynparza for:
  • Ovarian, fallopian tube, and primary peritoneal cancer
  • Breast cancer
  • Prostate cancer
  • Pancreatic cancer

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Wisconsin, Madison

Lead Sponsor

Trials
1,249
Recruited
3,255,000+

National Eye Institute (NEI)

Collaborator

Trials
572
Recruited
1,320,000+

Findings from Research

In a study involving 100 male military volunteers (55 non-musicians and 45 professional musicians), both groups performed similarly in recognizing speech in quiet environments, indicating no advantage for musical training in those conditions.
However, musicians significantly outperformed non-musicians in recognizing speech in noisy situations, suggesting that musical practice enhances the ability to discern speech amidst background noise.
[The effect of musical practice on speech recognition in quiet and noisy situations].Soncini, F., Costa, MJ.[2019]
A cognitive training intervention over 8 weeks significantly improved selective attention in 66 healthy older adults compared to a control group, indicating its efficacy in enhancing cognitive function.
Participants in the training group not only improved in the targeted attention skills but also showed benefits in other cognitive areas like processing speed and dual-task performance, suggesting broader cognitive enhancements from the training.
A cognitive training intervention improves modality-specific attention in a randomized controlled trial of healthy older adults.Mozolic, JL., Long, AB., Morgan, AR., et al.[2021]
Older listeners, even those with mild-to-moderate high-frequency hearing loss, can still effectively engage in lexically guided perceptual learning, indicating that this ability is resilient despite hearing challenges.
The study found that attention-switching control influences perceptual learning; listeners with poorer attention-switching control experienced a stronger learning effect, suggesting that reliance on acoustic information varies with attentional abilities.
The role of attentional abilities in lexically guided perceptual learning by older listeners.Scharenborg, O., Weber, A., Janse, E.[2018]

References

[The effect of musical practice on speech recognition in quiet and noisy situations]. [2019]
A cognitive training intervention improves modality-specific attention in a randomized controlled trial of healthy older adults. [2021]
The role of attentional abilities in lexically guided perceptual learning by older listeners. [2018]
Can We Train Multisensory Integration in Adults? A Systematic Review. [2023]
Auditory Learning Using a Portable Real-Time Vocoder: Preliminary Findings. [2018]
Feature-based attention enables robust, long-lasting location transfer in human perceptual learning. [2021]
Easy-to-hard effects in perceptual learning depend upon the degree to which initial trials are "easy". [2023]
Audio-Visual Spatiotemporal Perceptual Training Enhances the P300 Component in Healthy Older Adults. [2020]
Adaptive training diminishes distractibility in aging across species. [2022]
Perceptual learning: top to bottom. [2022]
The therapeutic benefits of perceptual learning. [2020]
12.United Statespubmed.ncbi.nlm.nih.gov
Perceptual learning. [2019]
13.United Statespubmed.ncbi.nlm.nih.gov
Perceptual learning, aging, and improved visual performance in early stages of visual processing. [2021]
14.United Statespubmed.ncbi.nlm.nih.gov
Recent progress in perceptual learning research. [2021]